18%–34% of colorectal cancer (CRC) patient samples show strong CXCR3 staining, and most of these CXCR3-positive patients are also diagnosed with lymph node metastasis (Abron et al., 2017). This evidence concerns the gene CXCR3 and metastatic malignant neoplasm in the lymph nodes.